×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TRIB – trinity biotech plc - american depositary shares each representing 4 a ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TRIB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/18
09:00 am
trib
Trinity Biotech Secures Major Regulatory Approval for Offshored and Outsourced Manufacturing of Its Market Leading Uni-Gold Rapid HIV Test, Further Accelerating Financial Performance Transformation
Medium
Report
Trinity Biotech Secures Major Regulatory Approval for Offshored and Outsourced Manufacturing of Its Market Leading Uni-Gold Rapid HIV Test, Further Accelerating Financial Performance Transformation
11/14
09:56 am
trib
Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test [Yahoo! Finance]
Low
Report
Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test [Yahoo! Finance]
11/14
09:00 am
trib
Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test
Medium
Report
Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test
10/29
02:59 pm
trib
Sepsis Diagnostics Market to Reach USD 1,790.9 million by 2032, Growing At An 7.85% CAGR - Credence Research
Low
Report
Sepsis Diagnostics Market to Reach USD 1,790.9 million by 2032, Growing At An 7.85% CAGR - Credence Research
10/29
02:58 pm
trib
Sepsis Diagnostics Market to Reach USD 1,790.9 million by 2032, Growing At An 7.85% CAGR - Credence Research
Low
Report
Sepsis Diagnostics Market to Reach USD 1,790.9 million by 2032, Growing At An 7.85% CAGR - Credence Research
10/27
09:00 am
trib
Trinity Biotech Welcomes Perceptive Advisor’s Indication of Potential Debt-to-Equity Conversion - Strengthening Balance Sheet and Supporting Growth
Medium
Report
Trinity Biotech Welcomes Perceptive Advisor’s Indication of Potential Debt-to-Equity Conversion - Strengthening Balance Sheet and Supporting Growth
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/4
08:27 pm
trib
Form SCHEDULE 13D/A TRINITY BIOTECH PLC Filed by: MiCo IVD Holdings, LLC
Low
Report
Form SCHEDULE 13D/A TRINITY BIOTECH PLC Filed by: MiCo IVD Holdings, LLC
11/21
10:02 am
trib
Form 6-K TRINITY BIOTECH PLC For: Nov 21
Low
Report
Form 6-K TRINITY BIOTECH PLC For: Nov 21
11/18
11:30 am
trib
Form 6-K TRINITY BIOTECH PLC For: Nov 18
Low
Report
Form 6-K TRINITY BIOTECH PLC For: Nov 18
10/24
07:30 pm
trib
Form SCHEDULE 13D/A TRINITY BIOTECH PLC Filed by: PERCEPTIVE ADVISORS LLC
Neutral
Report
Form SCHEDULE 13D/A TRINITY BIOTECH PLC Filed by: PERCEPTIVE ADVISORS LLC
10/23
04:33 pm
trib
Form 6-K TRINITY BIOTECH PLC For: Oct 23
Medium
Report
Form 6-K TRINITY BIOTECH PLC For: Oct 23
9/30
04:00 pm
trib
Form 6-K TRINITY BIOTECH PLC For: Sep 30
Low
Report
Form 6-K TRINITY BIOTECH PLC For: Sep 30
9/8
06:04 am
trib
Form 6-K TRINITY BIOTECH PLC For: Sep 08
Low
Report
Form 6-K TRINITY BIOTECH PLC For: Sep 08
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/31
Q4/2019 12/31/2019 EPS 0.090 ZacksConsensus N/A ActVsEst N/A - N/A
29.4%
4/10 Early Impacts of COVID-19 on Autoimmune Disease Diagnosis Market - Exclusive Report by MarketsandMarkets™ 12.1%
3/25 Insights into the Global Point of Care (POC) Infectious Disease Diagnostics Market (2019 to 2025) - Featuring Abbott Laboratories, Accu Biotech Co & Becton Among Others - ResearchAndMarkets.com 11.5%
4/20 Global Autoimmune Disease Diagnosis Industry to 2025 - Players Profiled Include Siemens, Abbott & Danaher Among Others - ResearchAndMarkets.com 10.2%
10/15 Global Healthcare-associated Infectious Disease Diagnostics Markets, 2018 & 2019-2024: Growing Penetration of POC Tests to Diagnose HAIs 10.0%
7/2 The global point of care diagnostic market is anticipated to grow at a CAGR of 9.28% between 2019 and 2027 to generate revenue of $57,482 million by 2027 9.7%
10/16 Form 6-K TRINITY BIOTECH PLC For: Oct 16 9.5%
3/5 Trinity Biotech latest coronavirus play, up 26% [Seeking Alpha] 9.4%
12/23 Global $37 Billion Point of Care Testing Market Forecast to 2025 - ResearchAndMarkets.com 6.3%
7/8 Form SC 13G/A TRINITY BIOTECH PLC Filed by: STONEHILL CAPITAL MANAGEMENT LLC 6.1%
4/10 Early Impacts of COVID-19 on Autoimmune Disease Diagnosis Market - Exclusive Report by MarketsandMarkets™ 12.1%
3/25 Insights into the Global Point of Care (POC) Infectious Disease Diagnostics Market (2019 to 2025) - Featuring Abbott Laboratories, Accu Biotech Co & Becton Among Others - ResearchAndMarkets.com 11.5%
4/20 Global Autoimmune Disease Diagnosis Industry to 2025 - Players Profiled Include Siemens, Abbott & Danaher Among Others - ResearchAndMarkets.com 10.2%
10/15 Global Healthcare-associated Infectious Disease Diagnostics Markets, 2018 & 2019-2024: Growing Penetration of POC Tests to Diagnose HAIs 10.0%
7/2 The global point of care diagnostic market is anticipated to grow at a CAGR of 9.28% between 2019 and 2027 to generate revenue of $57,482 million by 2027 9.7%
10/16 Form 6-K TRINITY BIOTECH PLC For: Oct 16 9.5%
3/5 Trinity Biotech latest coronavirus play, up 26% [Seeking Alpha] 9.4%
12/23 Global $37 Billion Point of Care Testing Market Forecast to 2025 - ResearchAndMarkets.com 6.3%
7/8 Form SC 13G/A TRINITY BIOTECH PLC Filed by: STONEHILL CAPITAL MANAGEMENT LLC 6.1%
TOP News Decliners
10/16
Q3/2019 9/30/2019 EPS 0.043 ZacksConsensus N/A ActVsEst N/A - N/A
-24.4%
3/2 Global Diabetes Diagnostics Industry -18.8%
8/20 Trinity Biotech Announces Results for Q2, 2019 -17.7%
3/31 Trinity Biotech plc's (TRIB) CEO Ronan O'Caoimh on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -14.7%
11/5 Trinity Biotech plc (NASDAQ: TRIB) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -14.4%
6/18 Global Glucose Monitoring Market Report 2019-2025 -11.8%
6/3 POC/Decentralized Diagnostic Testing Market, 2019-2023: Supplier Shares and Strategies, Country Forecasts for 300 Tests, Emerging Technologies, Instrumentation Review -7.9%
5/11 Trinity Biotech PLC (TRIB) CEO Ronan O'Caoimh on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -7.0%
10/15 Healthcare-associated Infectious Disease Diagnostics Market Report 2019 - Global Outlook and Forecast 2018-2024 - ResearchAndMarkets.com -6.6%
6/11 India POCT Market Revenue is Expected to Reach Over INR 4,000 Crore by FY'2023: Ken Research -6.3%
3/2 Global Diabetes Diagnostics Industry -18.8%
8/20 Trinity Biotech Announces Results for Q2, 2019 -17.7%
3/31 Trinity Biotech plc's (TRIB) CEO Ronan O'Caoimh on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -14.7%
11/5 Trinity Biotech plc (NASDAQ: TRIB) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -14.4%
6/18 Global Glucose Monitoring Market Report 2019-2025 -11.8%
6/3 POC/Decentralized Diagnostic Testing Market, 2019-2023: Supplier Shares and Strategies, Country Forecasts for 300 Tests, Emerging Technologies, Instrumentation Review -7.9%
5/11 Trinity Biotech PLC (TRIB) CEO Ronan O'Caoimh on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -7.0%
10/15 Healthcare-associated Infectious Disease Diagnostics Market Report 2019 - Global Outlook and Forecast 2018-2024 - ResearchAndMarkets.com -6.6%
6/11 India POCT Market Revenue is Expected to Reach Over INR 4,000 Crore by FY'2023: Ken Research -6.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: